Efficacy of supplementation with omegs-6/omegs-3 ratio of 4/1 and its relation to signaling in individuals with autism spectrum disorders
Not Applicable
Completed
- Conditions
- sutism spectrm disdorders
- Registration Number
- JPRN-jRCT1091220161
- Lead Sponsor
- main researcher in this study
- Brief Summary
Supplementation with omega-6/omrga-3 ratio of 4/1 remarkably improved ASD symptoms and upregulation of signaling.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
The Structured Clinical Interview (SCID) for the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition (DSM-IV) (First et al., 2002) was employed for diagnoses. For diagnoses of ASD, the semi-structured clinical interview based on the Autism Diagnostic Interview Revised (ADI-R) (Rutter et al., 2003) was also used.
Exclusion Criteria
(1) the presence of clinically significant abnormal laboratory data; (2) the presence of neurological disorders or sensory abnormalities; (3)a total IQ of less than 80
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method impaired communication, restricted interests, irritability
- Secondary Outcome Measures
Name Time Method Significant reduction of scores of the Aberrant Behavior Checklist compared to the baseline.